Apatitic fluoride increase in enamel from a topical treatment involving intermediate CaHPO4 . 2H2O formation, an in vivo study.
D000149:Acidulated Phosphate Fluoride / Q000378:metabolism; D000287:Administration, Topical; D001031:Apatites / Q000378:metabolism; D002130:Calcium Phosphates / Q000008:administration & dosage / Q000494:pharmacology*; D002327:Cariostatic Agents; D002648:Child; D003743:Dental Enamel / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D005460:Fluorides, Topical / Q000378:metabolism*; D006801:Humans; D008297:Male; D013997:Time Factors
D001031:Apatites; D002130:Calcium Phosphates; D002327:Cariostatic Agents; D005460:Fluorides, Topical; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; D000149:Acidulated Phosphate Fluoride; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous